Skip to main content
TipRanks
Go Ultimate75% OFF

Sinphar Pharmaceutical Co. Ltd. (1734) Balance Sheet

Sinphar Pharmaceutical Co. Ltd. Balance Sheet

Sinphar Pharmaceutical Co. Ltd.'s total assets for Q2 2026 were NT$6.84B, an increase of 6.59% from the previous quarter. TW:1734 total liabilities were NT$3.12B for the fiscal quarter, a 19.55% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 6.15BNT$ 6.30BNT$ 6.25BNT$ 6.19BNT$ 6.22B
NT$ 2.44BNT$ 2.75BNT$ 2.85BNT$ 2.97BNT$ 3.14B
NT$ 3.72BNT$ 3.55BNT$ 3.40BNT$ 3.22BNT$ 3.08B

Currency in TWD

Sinphar Pharmaceutical Co. Ltd. Liabilities to Assets

02.5B5B7.5B36 %42 %48 %54 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets